SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids

Kidney failure is frequently observed during and after COVID-19, but it remains elusive whether this is a direct effect of the virus. Here, we report that SARS-CoV-2 directly infects kidney cells and is associated with increased tubule-interstitial kidney fibrosis in patient autopsy samples. To study direct effects of the virus on the kidney independent of systemic effects of COVID-19, we infected human-induced pluripotent stem-cell-derived kidney organoids with SARS-CoV-2. Single-cell RNA sequencing indicated injury and dedifferentiation of infected cells with activation of profibrotic signaling pathways. Importantly, SARS-CoV-2 infection also led to increased collagen 1 protein expression in organoids. A SARS-CoV-2 protease inhibitor was able to ameliorate the infection of kidney cells by SARS-CoV-2. Our results suggest that SARS-CoV-2 can directly infect kidney cells and induce cell injury with subsequent fibrosis. These data could explain both acute kidney injury in COVID-19 patients and the development of chronic kidney disease in long COVID

Mouthpiece use during heavy resistance exercise affects serum cortisol and lactate

Recent reports suggest the use of mouthpieces may be beneficial at improving aerobic and anaerobic exercise performance. However, the mechanisms of these reported improvements have yet to be elucidated. The purpose of this study was to explore the possible mechanisms of improved performance using the ArmourBite® mouthpiece. Using a within subject randomized treatment design, 15 experienced resistance trained males (19–26 years of age) performed 6 sets of 10 repetitions of free weight back squats at 80% of 1RM with and without a mouthpiece. Blood samples were collected before exercise, after 3 sets (Mid), immediately post (Post), 30 min post (Post-30), 60 min post (Post-60) and 120 min post (Post-120) exercise. Samples were analyzed for lactate and ELISA was used to determine cortisol. Mouthpiece use resulted in more repetitions completed without assistance (54.36 ± 0.61 vs. 53.27 ± 0.79, p = 0.046) and fewer assisted repetitions (6.73 ± 0.79 vs. 5.64 ± 0.61 repetitions, p = 0.046) compared to the control group. Lactate concentrations were lower in the treatment vs. control group at the Post (11.54 ± 2.23 vs. 13.07 ± 2.96 mmol/L, p = 0.023) Post- 30 (4.45 ± 1.94 vs. 5.41 ± 1.90 mmol/L, p = 0.021), and Post-60 (2.07 ± 0.94 vs. 2.55 ± 0.96 mmol/L, p = 0.048) sampling periods. Mouthpiece use lowered cortisol levels at Mid and Post-30 (19.39 ± 6.90 vs. 27.84 ± 14.56 μg/dL, p = 0.02 (22.91 ± 8.47 vs. 31.81 ± 10.79 μg/dL, p = 0.04). Cortisol AUC values showed significant differences within the AUC Pre-Post control and treatment (55.16 ± 23.84 vs. 41.95 ± 2.65 μg/dL, p = 0.02) groups. These data suggest that mouthpiece use may increase performance and decrease stress when used during intense resistance exercise